Literature DB >> 14971867

Mood stabilizers and treatment adherence in bipolar disorder: addressing adverse events.

Michael Berk1, Lesley Berk.   

Abstract

Adverse events associated with lithium and anticonvulsant use in patients with bipolar disorder have been determined to decrease rates of treatment adherence; however, research that explores how adverse events influence treatment adherence, and which events have the greatest impact, is sparse and limited. This paper reviews the existing literature regarding common side effects encountered with lithium and anticonvulsant use in patients with bipolar disorder and presents data regarding their impact on treatment adherence. Guidelines for reducing and limiting adverse events are highlighted, as are recommendations for improving compliance associated with the experience of adverse events in the bipolar disorder population.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14971867     DOI: 10.1023/b:acli.0000008175.32403.8e

Source DB:  PubMed          Journal:  Ann Clin Psychiatry        ISSN: 1040-1237            Impact factor:   1.567


  4 in total

Review 1.  Lithium: updated human knowledge using an evidence-based approach: part III: clinical safety.

Authors:  Etienne Marc Grandjean; Jean-Michel Aubry
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

2.  Adaptation and validation of the "tolerability and quality of life" (TOOL) questionnaire in Chinese bipolar patients.

Authors:  Lin Xiao; Yulin Gao; Lili Zhang; Peiyun Chen; Xiaojia Sun; Siyuan Tang
Journal:  Qual Life Res       Date:  2016-05-23       Impact factor: 4.147

3.  Long-term treatment of bipolar disorder with a radioelectric asymmetric conveyor.

Authors:  Piero Mannu; Salvatore Rinaldi; Vania Fontani; Alessandro Castagna
Journal:  Neuropsychiatr Dis Treat       Date:  2011-06-15       Impact factor: 2.570

4.  Pharmacist counseling to cardiac patients in Israel prior to discharge from hospital contribute to increasing patient's medication adherence closing gaps and improving outcomes.

Authors:  Bishara Bisharat; Lubna Hafi; Orna Baron-Epel; Zaher Armaly; Abdalla Bowirrat
Journal:  J Transl Med       Date:  2012-03-01       Impact factor: 5.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.